STAT+: Up and down the ladder: The latest comings and goings

Protego Biopharma appointed Jae Kim as its new chief medical officer this week. Kim previously served as chief medical officer at both Septerna and Design Therapeutics. His appointment signals a significant move within the biopharmaceutical sector, bringing experienced leadership to Protego Biopharma's medical division. The company aims to leverage Kim's expertise to advance its research and development initiatives. This hiring is part of Protego Biopharma's broader strategy to strengthen its executive team and drive innovation in drug discovery and clinical trials. Kim's prior roles involved overseeing medical affairs and contributing to the strategic direction of therapeutic programs at his previous organizations.